Literature DB >> 16764952

Effects of acute and chronic relaxin-3 on food intake and energy expenditure in rats.

B M McGowan1, S A Stanley, K L Smith, J S Minnion, J Donovan, E L Thompson, M Patterson, M M Connolly, C R Abbott, C J Small, J V Gardiner, M A Ghatei, S R Bloom.   

Abstract

The effects of acute and repeated intraparaventricular (iPVN) administration of human relaxin-3 (H3) were examined on food intake, energy expenditure, and the hypothalamo-pituitary thyroid axis in male Wistar rats. An acute high dose iPVN injection of H3 significantly increased food intake 1 h post-administration [0.4+/-0.1 g (vehicle) vs 1.6+/-0.5 g (180 pmol H3), 2.4+/-0.5 g (540 pmol H3) and 2.2+/-0.5 g (1,620 pmol H3), p<0.05 for all doses vs vehicle]. Repeated iPVN H3 injection (180 pmol/twice a day for 7 days) significantly increased cumulative food intake in ad libitum fed animals compared with vehicle [211.8+/-7.1 g (vehicle) vs 261.6+/-6.7 g (ad libitum fed H3), p<0.05]. Plasma leptin was increased in the H3 ad libitum fed group. Plasma thyroid stimulating hormone was significantly decreased after acute and repeated administration of H3. These data suggest H3 may play a role in long-term control of food intake.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16764952     DOI: 10.1016/j.regpep.2006.04.009

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  35 in total

Review 1.  Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways.

Authors:  M L Halls; E T van der Westhuizen; R A D Bathgate; R J Summers
Journal:  Br J Pharmacol       Date:  2007-02-12       Impact factor: 8.739

Review 2.  Sex-specific effects of relaxin-3 on food intake and body weight gain.

Authors:  Juliane Calvez; Camila de Ávila; Elena Timofeeva
Journal:  Br J Pharmacol       Date:  2016-07-13       Impact factor: 8.739

3.  Distinct but overlapping binding sites of agonist and antagonist at the relaxin family peptide 3 (RXFP3) receptor.

Authors:  Lilian L L Wong; Daniel James Scott; Mohammed Akhter Hossain; Quentin Kaas; K Johan Rosengren; Ross A D Bathgate
Journal:  J Biol Chem       Date:  2018-08-21       Impact factor: 5.157

4.  Inhibition of oxytocin and vasopressin neuron activity in rat hypothalamic paraventricular nucleus by relaxin-3-RXFP3 signalling.

Authors:  Alan Kania; Anna Gugula; Agnieszka Grabowiecka; Camila de Ávila; Tomasz Blasiak; Zenon Rajfur; Marian H Lewandowski; Grzegorz Hess; Elena Timofeeva; Andrew L Gundlach; Anna Blasiak
Journal:  J Physiol       Date:  2017-02-27       Impact factor: 5.182

Review 5.  Relaxin family peptide systems and the central nervous system.

Authors:  G E Callander; R A D Bathgate
Journal:  Cell Mol Life Sci       Date:  2010-03-07       Impact factor: 9.261

6.  Relaxin peptide hormones are protective during the early stages of ischemic stroke in male rats.

Authors:  Lindsay H Bergeron; Jordan M Willcox; Faisal J Alibhai; Barry J Connell; Tarek M Saleh; Brian C Wilson; Alastair J S Summerlee
Journal:  Endocrinology       Date:  2014-12-02       Impact factor: 4.736

Review 7.  International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides.

Authors:  Michelle L Halls; Ross A D Bathgate; Steve W Sutton; Thomas B Dschietzig; Roger J Summers
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

8.  Transcriptional and pathway analysis in the hypothalamus of newly hatched chicks during fasting and delayed feeding.

Authors:  Stacy E Higgins; Laura E Ellestad; Nares Trakooljul; Fiona McCarthy; Jason Saliba; Larry A Cogburn; Tom E Porter
Journal:  BMC Genomics       Date:  2010-03-09       Impact factor: 3.969

9.  Relaxin-3/RXFP3 system regulates alcohol-seeking.

Authors:  Philip J Ryan; Hanna E Kastman; Elena V Krstew; K Johan Rosengren; Mohammed Akhter Hossain; Leonid Churilov; John D Wade; Andrew L Gundlach; Andrew J Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

10.  Prokineticin 2 is a hypothalamic neuropeptide that potently inhibits food intake.

Authors:  James V Gardiner; Attia Bataveljic; Neekhil A Patel; Gavin A Bewick; Debabrata Roy; Daniel Campbell; Hannah C Greenwood; Kevin G Murphy; Saira Hameed; Preeti H Jethwa; Francis J P Ebling; Steven P Vickers; Sharon Cheetham; Mohammad A Ghatei; Stephen R Bloom; Waljit S Dhillo
Journal:  Diabetes       Date:  2009-11-23       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.